Form 4: HCI Group's General Counsel, Andrew L. Graham, Sells Shares to Diversify Investment Holdings
SEC Form 4 Filing
Andrew L. Graham, General Counsel of HCI Group, Inc., sold shares of common stock to improve the diversification of his investment holdings.
Summary
- On April 3, 2024, Andrew L. Graham, the General Counsel of HCI Group, Inc., sold 29,008 shares of common stock at a weighted average price of $117.0061 per share.
- He also sold 235 shares at a weighted average price of $116.0265 per share.
- On April 4, 2024, he sold 2,839 shares at $116.1005 per share.
- These transactions were aimed at modestly improving the diversification of his investment holdings.
- Following these transactions, Graham directly owns 21,819 shares and indirectly owns 0 shares through his IRA.
- He also holds restricted stock grants: 875 shares vesting on May 20, 2024, 750 shares vesting on February 26, 2025, and 34,000 shares that vest if the company's stock price reaches $140 for 30 consecutive days.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The document primarily reports on the sale of shares by an insider for diversification purposes, which doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The document does not explicitly contain any positive information about the company's performance or outlook.
Negatives
- The sale of shares by a company officer could be perceived negatively by some investors, although the stated reason is diversification.
Risks
- While the stated reason for the sale is diversification, there is always a risk that investors may interpret insider sales as a lack of confidence in the company's future prospects.
- The vesting of 34,000 restricted shares is contingent on the company's stock price reaching $140 for 30 consecutive days, which may or may not occur.
Future Outlook
The document does not contain any specific forward-looking statements about the company's future performance.
Management Comments
- The reporting person is seeking to improve modestly the diversification of his investment holdings.
Industry Context
Insider sales are a common occurrence in publicly traded companies. They are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, it's important to consider the context of the sale, such as diversification needs, tax planning, or other personal financial considerations.
Comparison to Industry Standards
- Comparing insider trading activity to peers in the insurance industry is difficult without specific data on those peers.
- Generally, insider sales are evaluated based on the size of the transaction relative to the individual's holdings and the overall trading volume of the stock.
- A small sale for diversification purposes is viewed differently than a large sale by multiple insiders.
Stakeholder Impact
- The sale of shares by a company officer could have a minor impact on shareholder sentiment, depending on how it is perceived by the market.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 05/26/2020 | Effective date of restricted stock grant of 3,500 shares. |
| 05/20/2021 | First vesting date for restricted stock grant of 3,500 shares (875 shares). |
| 02/26/2021 | Effective date of restricted stock grant of 3,000 shares and 34,000 shares. |
| 02/26/2022 | First vesting date for restricted stock grant of 3,000 shares (750 shares). |
| 05/20/2022 | Second vesting date for restricted stock grant of 3,500 shares (875 shares). |
| 02/26/2023 | Second vesting date for restricted stock grant of 3,000 shares (750 shares). |
| 05/20/2023 | Third vesting date for restricted stock grant of 3,500 shares (875 shares). |
| 04/03/2024 | Date of common stock sales. |
| 04/04/2024 | Date of common stock sales. |
| 04/05/2024 | Date of signature on the Form 4 filing. |
| 05/20/2024 | Final vesting date for restricted stock grant of 3,500 shares (875 shares). |
| 02/26/2025 | Final vesting date for restricted stock grant of 3,000 shares (750 shares). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.